Izotropic Accelerates Payor Engagement Activities with Excite International
Izotropic Corporation, a company commercializing true 3D, dedicated breast CT imaging technology for the earlier detection of breast cancers, is pleased to announce it has partnered with EXCITE International (EXCITE), a global network of payors, health systems, patients, scientists, and end-users, to prepare for future commercial adoption of the IZOview.
Learn More at finance.yahoo.com
EXCITE International & Izotropic Corporation Announce Partnership
With this EXCITE partnership, Izotropic will engage with EXCITE’s global network to align the device, clinical trial design, and regulatory strategy with potential payor groups, methodologists, and expert end-users.
2020 Summit Plans Are Underway
We are pleased to announce that plans for the annual EXCITE International Summit are underway. A more formal separate announcement will be made as soon as the Planning and Program Committees have been struck and the venue confirmed. ...
New Executive Board Member
EXCITE International is pleased to announce the appointment of Dr. Jeff Popma to its Board. Jeff is Chair of EXCITE International’s Scientifi...
New Chair for EXCITE International Payers' Advisory Committee
EXCITE International wishes to announce that Naomi Aronson will be stepping down as Chair of the Payers’ Advisory Committee (PAC) effective August 31st. We are, at the same time pleased to announce that Jo Carol Hiatt, Chair of the Inter-Regional New Technology Committee at Kaiser Permanente has agreed to succeed Naomi as Chair.
Payers' Advisory Committee Membership Grows by Two
EXCITE International's Payers' Advisory Committee welcomes two new members. Robert Garnett is President, Amerigroup Tennessee, part of the Medicaid Central Region and Government Business Division at Anthem, Inc. where he is responsible for the strategic, fiscal, regulatory, and operational leadership of the health plan. Stig A. Slørdahl MD, is CEO of The Central Norway Regional Health Authority. He was dean of the Faculty of Medicine at the Norwegian University of Science and Technology (NTN...
New Scientific Collaboration Chair Appointed
EXCITE International is pleased to announce the appointment of Jeffrey J. Popma, MD as chair of its Scientific Collaboration. This appointment follows the retirement of Dr Bryan Luce who has been chair since the inception of EXCITE International in 2016.
EXCITE International Health Technology Global Summit - Proceedings
EXCITE International held a Health Technology Global Summit in Washington, DC in March 2019. The event was well attended and very well received. To learn more about the Summit, Read more
EXCITE International Update June 2018
EXCITE International is pleased to share with you recent news highlighting the ongoing expansion and partnership development taking place in our organization. Get acquainted with our new executive board members, Sir Bruce Keogh and Carl Christian Gilhuus-Moe in addition to latest developments in our offerings, invaluable partnerships, the launch of new board committees and recent meetings and presentations.
EXCITE International Model Sparks Immediate Interest in the Silicon Valley
EXCITE International’s approach to accelerating health technology innovation generated immediate interest at the 9th Annual Medical Technology Executive Forum hosted by the Medical Device Manufacturers Association (MDMA) in Palo Alto, California on September 29, 2016.
EXCITE International Convenes Key Leaders in Inaugural Summit
EXCITE International (Excellence in Clinical Innovation & Technology Evaluation) convened high-level health care leaders from around the world at an inaugural multijurisdictional Summit on June 2-3, 2016 in Toronto.
EXCITE International Establishes Executive Board, Names Officers
The inaugural meeting of the Executive Board for EXCITE International occurred in Toronto on Feb 23, 2016.
EXCITE International Incorporated in October 2015
Incorporated in March 2016, EXCITE International represents a major positive disruption in the application of evidence to the evaluation of technology and has the potential to be a first-of-its kind global engine for medical technology innovation.